Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yunmeng Nie

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 20, 2022
The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better PrognosisYunmeng Nie, Fang Huang, Lihua Lou, et al.
Frontiers in Pharmacology|July 22, 2021
Natural Compounds: A Potential Treatment for Alcoholic Liver Disease?Junbin Yan, Yunmeng Nie, Minmin Luo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|August 4, 2024
Mechanistic study of fructus aurantii (Quzhou origin) in regulating ileal reg3g in the treatment for NASHJunbin Yan, Yunmeng Nie, Xinli Chen, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 18, 2026
Dihydrotanshinone I suppresses glycolysis and gastric cancer growth by targeting the nuclear FBXW11/LTN1/PKM2 axisYunmeng Nie, Xing Bai, Mingsi Zhang, et al.
Frontiers in Pharmacology|February 27, 2023
The IDI1/SREBP2 axis drives intrahepatic cholestasis and is a treatment target of San-Huang-Cai-Zhu formula identified by sequencing and experimentsJunbin Yan, Yunmeng Nie, Zheng Chen, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 4, 2024
Dihydrotanshinone I targets ESR1 to induce DNA double-strand breaks and proliferation inhibition in hepatocellular carcinomaYunmeng Nie, Junbin Yan, Xueru Huang, et al.
Journal of Immunology Research|June 23, 2022
Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and ExperimentsBeihui He, Zheng Chen, Yunmeng Nie, et al.
Frontiers in Medicine|June 27, 2022
Screening New Blood Indicators for Non-alcoholic Fatty Liver Disease (NAFLD) Diagnosis of Chinese Based on Machine LearningCheng Wang, Junbin Yan, Shuo Zhang, et al.
Frontiers in Cardiovascular Medicine|April 19, 2021
The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic DiseasesJunbin Yan, Yunmeng Nie, Jielu Cao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 24, 2025
Quzhou-sourced Fructus Aurantii ameliorates MASLD by modulating glycolysis-dependent M1 polarization in hepatic macrophagesJunbin Yan, Yunmeng Nie, Menglu Ding, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 20, 2022
The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better PrognosisYunmeng Nie, Fang Huang, Lihua Lou, et al.
Frontiers in Pharmacology|July 22, 2021
Natural Compounds: A Potential Treatment for Alcoholic Liver Disease?Junbin Yan, Yunmeng Nie, Minmin Luo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|August 4, 2024
Mechanistic study of fructus aurantii (Quzhou origin) in regulating ileal reg3g in the treatment for NASHJunbin Yan, Yunmeng Nie, Xinli Chen, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 18, 2026
Dihydrotanshinone I suppresses glycolysis and gastric cancer growth by targeting the nuclear FBXW11/LTN1/PKM2 axisYunmeng Nie, Xing Bai, Mingsi Zhang, et al.
Frontiers in Pharmacology|February 27, 2023
The IDI1/SREBP2 axis drives intrahepatic cholestasis and is a treatment target of San-Huang-Cai-Zhu formula identified by sequencing and experimentsJunbin Yan, Yunmeng Nie, Zheng Chen, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 4, 2024
Dihydrotanshinone I targets ESR1 to induce DNA double-strand breaks and proliferation inhibition in hepatocellular carcinomaYunmeng Nie, Junbin Yan, Xueru Huang, et al.
Journal of Immunology Research|June 23, 2022
Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and ExperimentsBeihui He, Zheng Chen, Yunmeng Nie, et al.
Frontiers in Medicine|June 27, 2022
Screening New Blood Indicators for Non-alcoholic Fatty Liver Disease (NAFLD) Diagnosis of Chinese Based on Machine LearningCheng Wang, Junbin Yan, Shuo Zhang, et al.
Frontiers in Cardiovascular Medicine|April 19, 2021
The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic DiseasesJunbin Yan, Yunmeng Nie, Jielu Cao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 24, 2025
Quzhou-sourced Fructus Aurantii ameliorates MASLD by modulating glycolysis-dependent M1 polarization in hepatic macrophagesJunbin Yan, Yunmeng Nie, Menglu Ding, et al.
Pageof 2